SOPHiA GENETICS SA Cash Flow from Investing Activities 2020-2023 | SOPH
SOPHiA GENETICS SA cash flow from investing activities from 2020 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| SOPHiA GENETICS SA Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $8 |
| 2022 | $42 |
| 2021 | $-57 |
| 2020 | $-24 |
| 2019 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.329B | $0.062B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.426B | 20.00 |
| Inspire Medical Systems (INSP) | United States | $7.603B | 0.00 |
| Axonics (AXNX) | United States | $3.448B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.323B | 0.00 |
| 10x Genomics (TXG) | United States | $3.247B | 0.00 |
| Azenta (AZTA) | United States | $3.087B | 251.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.879B | 0.00 |
| Enovis (ENOV) | United States | $2.793B | 20.70 |
| Hims & Hers Health (HIMS) | United States | $2.496B | 0.00 |
| Privia Health (PRVA) | United States | $2.264B | 100.42 |
| Schrodinger (SDGR) | United States | $1.739B | 0.00 |
| Omnicell (OMCL) | United States | $1.377B | 47.59 |
| Phreesia (PHR) | United States | $1.279B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.865B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.539B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
| Pulmonx (LUNG) | United States | $0.360B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.357B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.229B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.202B | 0.00 |
| Outset Medical (OM) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.164B | 0.00 |
| Augmedix (AUGX) | United States | $0.132B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.07 |
| 111 (YI) | China | $0.097B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.074B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| Zepp Health (ZEPP) | China | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |